|
G. Bedetti1, C. Pizzi2, G.
Gavaruzzi3, F. Lugaresi4, A. Cicognani4,
E. Picano5
1Hospital
S. Maria della Scaletta, Imola, Italy, 2Department of
Internal Medicine, Cardioangiology, Epatology, University of Bologna,
3S. Orsola Hospital Nuclear Cardiology, 4Department
of Medicine and Public Health, Section of Legal Medicine, University of
Bologna, 5CNR,
Institute of Clinical Physiology, Pisa, Italy
Address for correspondence:
Eugenio Picano, MD, PhD
CNR, Institute of Clinical Physiology
Via Moruzzi,1
56124 Pisa
Italy
Phone: 0039-50-3152400
Fax: 0039-50-3152374
Abstract
Background: A too
detailed information on radiological dose and risk may result in undue
anxiety. An information economical with the truth may violate basic
patients’ rights well embedded in ethics (Oviedo convention 1997) and
law (97/43 Euratom Directive 1997).
Aim: To assess the
information perceived by patients on radiological dose of exams they
perform
Methods: Multiple
choice survey of patients undergoing a cardiac rest-stress
Technetium-99m sestamibi scan, which gives an effective dose of 10
milliSievert (mSv), corresponding to a dose equivalent of 500 chest
x-rays (European Commission Medical Imaging Guidelines 2001) and an
estimated extra lifetime attributable risk of 1 cancer in 1,000 exposed
subjects (Biological Effects of Ionizing Radiation VII Committee 2005).
Results: One hundred
and nine patients (66 men, age 66±10
years) were included. One out of 5 patients, with the remaining
underestimating of at least 300 times their own exposure, correctly
estimated dose exposure. One out of 4 patients, with 1 out of 3
substantially underestimating their own risk, correctly described
estimated risk.
Conclusion: Patients
undergoing common cardiac imaging examinations involving significant
exposure have little or no awareness about
radiological dose exposure (and corresponding risk). This ineffective
communication poses significant ethical problems, with high litigation
potential.
Introduction
Every radiological and nuclear medicine examination
confers a definite (albeit low) long-term risk of cancer, but patients
undergoing such examinations often receive no or inaccurate information
about these risks, directly related to the radiological dose received
(1,2). A too detailed information on
radiological dose and risk may result in undue anxiety, but an
information “economical with the truth” may violate basic patients’
rights well embedded in ethics (Oviedo convention 1997) (3) and law
(97/43 Euratom
Directive 1997) (4). In fact one of the three fundamental principles of
the “charter of medical professionalism” in the new millennium is the
principle of patient autonomy: “Physicians must empower their patients
to make informed decisions about their treatment” (5). How are these
generally accepted principles translated into clinical practice
involving common ionizing testing? The aim of this study was to assess
the information perceived by patients on radiological dose of common
nuclear medicine exams they frequently perform.
Methods
The
questionnaire evaluated the awareness of physical radiation dose and of
the associated cancer risk. The effective dose
is the sum of the absorbed doses in all organs of the
body, each weighted according to their radiation sensitivity. The
relative effective dose was expressed in milliSievert (mSv), and in
terms of chest X-ray equivalent units, a method of communication
previously found to be user-friendly to physicians and patients (6-8)
and endorsed as an effective way to communicate radiological risk by the
UK College of Radiologists (6), EU Medical Imaging guidelines (7), and
Italian National Medical Imaging guidelines (8).
The dose exposure is 0.02 mSv for a single
postero-anterior chest X-ray (7-9). Cardiac rest-stress
Technetium-99m sestamibi scan gives an effective dose of 10 mSv,
corresponding to a dose equivalent of 500 chest x-rays (European
Commission Medical Imaging Guidelines 2001) (9). The estimated extra
lifetime attributable risk corresponds to 1 cancer in 1000 exposed
subjects (Biological Effects of Ionizing Radiation VII Committee 2005)
(10).
The survey
was performed in Nuclear Medicine of
Sant’Orsola-Malpighi Hospital (Bologna, Italy).
Responses were tailored to a multiple-choice format to aid ease
completion. Radiological information of patients was collected,
before the examination, by a structured
written questionnaire which consisted
of 4 very simple questions regarding: 1) perception of individual
biorisks; 2) perception of dose exposure of cardiac rest-stress
Technetium-99m sestamibi scan; 3)
information perceived by the prescribing
physician; and 4) information perceived
by the physician practising myocardial
stress perfusion scintigraphy. Each
question had 4 multiple-choice answers (only
one correct).
Question 1): “The long-term
extra-risk of cancer for a stress cardiac perfusion scintigraphy is”:
Answers: a) 0 (zero); b) 1 in 1 million (minimal); c) 1 in 100,000 tests
(very low); d) 1 in 1000 tests (low). The correct answer is d) (10).
Question 2): “The radiological
exposure of a myocardial stress perfusion scintigraphy is”: Answers: a)
0 (zero); b) similar to a chest X-ray; c) one-half a chest X-ray; d) 500
times a chest X-ray. The correct answer is d) (9).
Question 3): “the
information perceived by the patient after interaction with the
prescribing physicians was”: Answers:
a) excellent, as the patient received the information about the
benefits, the doses and the long term risks; b) good, as he/she was
informed about the benefits and the doses; c) sufficient as he/she was
informed about the benefits; d) poor, as he/she was not informed about
the benefits, the doses and the long term risks.
Question 4): “the
information perceived by the patient after interaction with the
practising physician was”: a) excellent; b) good; c) sufficient; d)
poor, all defined as in question 3.
Statistical analysis
The statistical analyses of the data were performed
with SPSS (version 11.0, SPSS Inc., Chicago, Illinois). Descriptive data
were reported as charts, percentages, means and standard deviations. The
results of each question were treated in a binary fashion
(correct/wrong, 1/0).
Results
One hundred and nine patients (66 men, age 66±10)
were included. Dose exposure was correctly estimated by 27% of patients,
with the remaining 73% underestimating of at least 300 times their own
exposure (Fig. 1). Eighty percent wrongly estimated the dose exposure
of myocardial stress perfusion
scintigraphy as equal to “zero” or to “one”, or “one-half”
that of a chest X-ray or “don’t say”(Fig. 2). Only 11% of patients has
judged excellent the information perceived by the physician prescribing
the exam as it has talked to him about the benefits, the doses and the
long-term risks (Fig. 3). Of note, however, of this 11% of patients who
received “excellent” information, 92% substantially estimated the risk
of cancer and doses (Fig. 3). Only 21% of patients have judged excellent
the information perceived by the practising
physician (Fig. 4). Of note, however, of this 21% who thought they
received “excellent” information, 87% substantially underestimated the
doses and the risks of the examination they performed.
Discussion
Informed consent for radiological examinations is
often not sought, and when it is, patients are often not fully informed,
even for considerable levels of radiation exposure and long term risk
(2). Dose exposure of myocardial stress perfusion scintigraphy was
correctly estimated by 1 out of 5 patients, with the remaining
underestimating of at least 300 times, and estimated risk was correctly
described by 1 out of 4 patients, with 1 out of 3 substantially
underestimating their own risk.
Comparison
with previous studies
Our data are consistent with previous, extensive data
showing substantial unawareness of radiological doses, and risks, not
only of patients but of prescribing and practising doctors as well. In
theory, good medical practice warrants knowledge of the doses and
long-term risks of these tests – which can be judiciously employed when
they are most appropriate. The results of a survey performed on British
physicians shows that 1 out of 20 doctors does not realise that
ultrasound does not use ionizing radiation, that 1 out of 10 does not
realise that magnetic resonance imaging does not use ionizing radiation,
and 97% of doctors grossly underestimate (on average by sixteen times)
the doses of radiation for most commonly requested investigations (11).
Another survey on Israeli orthopaedists shows that the mortality risk of
radiation induced carcinoma from bone scan has been identified correctly
by less than 5% of respondents and senior orthopaedists estimated lower
risks than did residents (12). Among radiologists, 5% of respondents
thought that a computed tomography scan dose was less than one chest
radiograph, and 56% estimated the computed tomography scan dose between
1 and 10 chest radiographs, with dramatic underestimation of the true
dose (about 500 chest radiographs) (13). In another survey conducted in
a tertiary care referral centre of adult and paediatric cardiology, the
correct dose of a stress sestamibi myocardial scintigraphy
(corresponding to 500 chest x-rays) was correctly estimated by 29% of
physicians, whereas 71% wrongly estimated the dose exposure as equal to
one (13% of respondents), or one half (9%) or three times (49%) that of
a chest x-ray (14). A similar, stunning unawareness was found among
pediatricians. When estimating the effective dose of various pediatric
radiological investigations, 87% of all responses were underestimates
and only 6% were correct in their estimates of the quoted lifetime
excess cancer risk associated with radiation doses equivalent to
pediatric CT. Forty % of pediatricians underestimated of 100-1000 times
the dose of a CT head pre- and post-contrast and 4% thought that
abdominal ultrasound scan was associated to ionizing radiation exposure
(15). Only 15% of radiology institutions inform patients about radiation
risks of a CT scan, whereas 84% inform about allergic risks (16). This
may help to explain why 30% of tests involving ionising radiation are
inappropriate, that is, patients take a long-term risk without a
commensurate acute benefit (15-17).
The proposal of a new standard of informed consent
form
Non-specialists (and sometimes specialists) often do
not understand the difficult jargon of radiation protection, in which
doses are expressed in different, often exoteric, units (megaBecquerel,
milliCuries, kilovolts, dose-area product, etc), and simple information
on doses and risks is difficult to find and hard to interpret (2). The
pressures of an old-fashioned paternalistic view of medicine and of a
more modern efficientism act against the building of a really informed
consent (2). Nevertheless, in an “ideal” informed consent form, the
principle of patient autonomy in current radiological practice might
be reinforced by making it mandatory to obtain explicit and transparent
informed consent form for radiological examination with high exposure
(≥500 chest x-rays) (2). The form should spell out the type of
examination, the exposure in effective dose (mSv), the dose equivalent
in number of chest radiographs, the lost life expectancy (days), the
equivalent period of natural background radiation (years) and the risk
of cancer as number of extra cases in the exposed population. Table 1
reports an example applied to 4 types of stress perfusion imaging with 4
different protocols: Tc-99m tetrofosmin rest stress (10 mSv); Tc-99m
sestamibi 2-day stress rest (17 mSv); Tl-201 stress and reinjection (25
mSv); Dual-isotope (Tl-201 and Tc-99m) stress imaging (16). The
associated proposed graph (Fig.5) underlines the linear relation between
dose and risk and might be useful for passing information from doctors
to patients and between doctors because the figure format is more easily
understood than the traditional table format and the colour coding helps
readers to understand risk levels (2). This simple, evidence based
communication strategy, if used when obtaining informed consent, will
increase the currently suboptimal level of radiological awareness among
doctors and patients. Better knowledge of risks will help us to avoid
small individual risks translating into substantial population risks
(17-19). Consent forms would also help reduce pressure from patients for
redundant and often useless examinations (20).
Conclusion
Patients undergoing common imaging examinations
involving significant exposure have little or no awareness
about radiological dose exposure (and
corresponding risk). This ineffective communication poses significant
ethical problems, with high litigation potential. Informed consent is a
procedure needed to establish a respectful and ethical relation between
doctors and patients.
References
-
Picano E. (2005) Economic and
biological costs of cardiac imaging.
Cardiovascular Ultrasound 3: 13 (http://www.cardiovascularultrasound.com/content/3/1/13).
-
Picano E (2004) Informed consent
and communication of risk from radiological and nuclear medicine
examinations: how to escape from a communication inferno. BMJ 329:
849-851.
-
Convention for the Protection of Human Rights and
Dignity of the Human Being with regard to the Application of Biology
and Medicine: Convention on Human Rights and Biomedicine.
http://conventions.coe.int/treaty/en/treaties/html/164.htm
-
Council Directive 97/43/EURATOM of
30 June 1997 on health protection of individuals against the dangers
of ionizing radiation in relation to medical exposure and repealing
Directive 84/466/Euratom.
http://ec.europa.eu/energy/nuclear/radioprotection/doc/legislation/9743_en.pdf
-
Medical professionalism in the new
millennium: a physicians charter. JAMA 2002; 243- 6.
-
ICRP (1991) 1990 Recommendations
of the International Commission on Radiological Protection. ICRP
publication no.60. Pergamon, Oxford
-
RCR - Royal College of Radiology.
Making the best use of a department of clinical radiology:
guidelines for doctors. 4th Ed. 1998
-
European
Commission. Radiation protection 118: referral guidelines for
imaging. Luxembourg: Office
for Official Publications of the European Communities, 2001.
http://europa.eu.int/comm/environment/radprot/
118/rp-118-en.pdf (acessed 30 Sep 2004)
-
Italian
Health Ministry Medical Imaging Guidelines 2004.
Linea guida Agenzia
Servizi Sanitari Regionali e Istituto Superiore Sanità sulla
diagnostica per immagini..
http://www.sirm.org/professione/pdf_lineeguida/linee_diag_x_img.pdf
-
BEIR VII, release 2005
http://www.nap.edu/reportbrief/11340rb.pdf
-
Shiralkar S, Rennie A, Snow M,
Galland RB, Lewis MH, Gower-Thomas K.
(2003) Doctors’ knowledge
of radiation exposure: questionnaire study. BMJ 327: 371-372.
-
Finestone A, Schlesinger T, Amir
H, Richter E, Milgrom C (2003) Do physicians correctly estimate
radiation risks from medical imaging? Arch Environ Health. 58:59-61
-
Correia MJ, Hellies A, Andreassi
MG, Ghelarducci B, Picano E (2005) Lack of radiological awareness
among physicians working in a tertiary-care cardiological centre.
International Journal of Cardiology 105: 307– 311
-
Lee CI, Haims AH, Monico EP, Brink
JA, Forman HP (2004).
Diagnostic CT scans: assessment of patient, physician, and
radiologist awareness of radiation dose and possible risks.
Radiology 231:393-8
-
Thomas KE, Parnell-Parmely JE, Haidar
S, Moineddin R, Charkot E, BenDavid G, Krajewski C (2006) Assessment
of radiation dose awareness among pediatricians. Pediatric Radiol DOI
10.1007/s00247-006-0170-
-
Thompson RC, Cullom SJ (2006)
Issues regarding radiation
dosage of cardiac nuclear and radiography procedures. J Nucl
Cardiology 13: 19-23
-
Picano E (2004)
Sustainability of medical imaging.
BMJ 328:578-80
-
Berrington de Gonzalez A, Darby S.
(2004) Risk of cancer from
diagnostic X-rays: estimates for the UK and 14 other countries.
Lancet. 363:345-51
-
Picano E (2004) Risk of cancer
from diagnostic X-rays. Letter. Lancet 363:1909-10
-
Welch GH, Schwartz L, Woloshin S
(2007) "What's Making Us Sick Is an Epidemic of Diagnoses". New York
Times.
http://nytimes.com
Table 1. Ways to communicate risk
|
Procedure |
Effective Radiation Dose (mSv) |
Equivalent Number of chest radiographs |
Lost life expectancy (days) |
Equivalent period of natural background
radiation (years) |
Lifetime additional risk of
cancer/examination |
|
Tetrofosmin |
10 |
500 |
2 |
4 |
1 in 1000 |
|
Sestamibi 2-days |
7 |
850 |
3 |
6.5 |
1 in 600 |
|
Thallium scan |
25 |
1250 |
4 |
10 |
1 in 400 |
|
Dual
isotope |
27 |
1350 |
4.5 |
11 |
1 in 200 |
|